Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis

INTRODUCTION: The predictive strength and accuracy of some biomarkers for the pathological complete response (pCR) to neoadjuvant therapy for HER2-positive breast cancer remain unclear. This study aimed to compare the accuracy of the HER2-enriched subtype and the presence of PIK3CA mutations, namely...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Fuxing, Huo, Xingfa, Wang, Miaozhou, Liu, Zhen, Zhao, Yi, Ren, Dengfeng, Xie, Qiqi, Liu, Zhilin, Li, Zitao, Du, Feng, Shen, Guoshuang, Zhao, Jiuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581664/
https://www.ncbi.nlm.nih.gov/pubmed/34778044
http://dx.doi.org/10.3389/fonc.2021.731148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581664/
https://www.ncbi.nlm.nih.gov/pubmed/34778044
http://dx.doi.org/10.3389/fonc.2021.731148

Ejemplares similares